Outlook Therapeutics (OTLK)'s 30-day implied volatility (IV30) was 110.5% at the close on November 13, 2026, up from 99.3% the day before, against a 52-week range of 77.4% to 392.6%. Its 20-day historical volatility was 85.9%.
Data as of November 13, 2026.